TheraLeaf announces application to UK’s MHRA for approval on medical cannabis tinctures

Barcelona, Spain – April 14th, 2020

TheraLeaf has officially applied to the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) for preliminary approval on its medical cannabis tinctures. TheraLeaf looks forward to providing all necessary documentation showing the safety, efficacy and specification of its medical cannabis products for UK distribution. Currently, the United Kingdom has over 20,000 patients in its burgeoning medical cannabis program with that figure expected to triple by the end of 2020. 

Leave a Reply

Your email address will not be published. Required fields are marked *